当前位置: X-MOL首页全球导师 国内导师 › 刘良

个人简介

刘良,1990年毕业于广州中医药大学,获医学博士学位(中西医结合研究方向)。1992年赴德国汉诺威医学院分子药理研究所及爱尔兰根-纽伦堡大学马普研究协会(德国科学院)风湿病与免疫研究所从事中药抗炎免疫药理研究,回国后于1997年出任广州中医药大学副校长、教授、博士生导师。2000年8月透过“输入内地优秀人才计划”前往香港工作,出任浸会大学中医药学院常务副院长及教授,2001年1月升任为该院奠基院长并任职至2011年6月止, 2007年4月晋升为该校终身讲座教授。2011年7月起,刘良担任澳门科技大学副校长,负责管理全校的研究及拓展事务。2013年1月起,接任澳门科技大学校长。 刘良在2011年加入澳门科技大学后,与大学高层管理团队密切配合,努力推动大学的科学研究发展向国际水准迈进,使大学在科研管理、科研项目与成果、学术交流与研究声誉等方面,均取得了显着进步。廖泽云表示澳门科技大学基金会、校董会将全力支持刘良的工作,办好大学,服务社会。 学历 1992 –1994德国汉若威医学院及马普风湿病与免疫研究所/抗炎免疫药理研究/访问学者 1991 –1992 上海外国语大学/德语培训 1987 –1990广州中医药大学/中西医结合/ 博士学位 1983 –1985广州中医药大学/ 中西医结合/ 硕士学位 1978 –1982广州中医学院/ 中医学/ 学士学位 1975 –1977 常德地区卫生学校/ 西医学/ 医士工作经验 2013.1-现职澳门科技大学/ 校长、讲座教授中药质量研究国家重点实验室/ 主任 2011.7 -2012.12澳门科技大学/ 副校长、讲座教授中药质量研究国家重点实验室/ 主任 2009.9 –2011.6香港浸会大学/ 中医药学院/ 院长、讲座教授香港浸会大学/ 岑尧宽岑碧泉纪念癌症炎症研究中心/ 主任 2007.4 –2009.8香港浸会大学/ 中医药学院/ 院长、讲座教授 2001.1 –2007.3香港浸会大学/ 中医药学院/ 院长、教授 2000.8 -2000.12香港浸会大学/ 中医药学院/ 常务副院长、教授 1997.9 -2000.7广州中医药大学/ 副校长、教授 1996.6 -1997.8广州中医药大学/ 校长助理、副教授 1991.8–1996.5广州中医药大学/ 副教授 1990.8 –1991.7广州中医学院/讲师 1986.1 -1987.8广州中医学院/ 讲师

研究领域

临床中药学、中药分子药理、抗关节炎与抗癌创新药物、中药质量控制技术与方法

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

50Zhu GY,Chen G,LiuL,Bai LP,Jiang*,ZH.C-17 lactam-bearinglimonoids from the twigs and leaves of Amoora tsangii.J Nat Prod.2014Apr 25;77(4):983-9.49Wang JR,Yau LF,Gao W,Liu Y,Yick PW,LiuL*,., JiangZH*.Quantitative Comparison and Metabolite Profiling of Saponins in DifferentParts of the Root ofPanax notoginseng.J Agric Food Chem.2014 Aug 13.48Wang JR,Zhang H,Yau LF,Mi JN,Lee S,Lee KC,Hu P,LiuL*andJiangZH*.Improved sphingolipidomic approach based on ultra-highperformance liquid chromatography and multiple mass spectrometries withapplication to cellular neurotoxicity.Anal Chem.2014 Jun 17: 86(12):5688-96.47 Fan XX,Li N,Wu JL,Zhou YL,He JX,Liu L,Leung EL*. Celastrolinduces apoptosis in gefitinib-resistant non-small cell lung cancer cellsvia caspases-dependent pathways and Hsp90 client protein degradation.Molecules.2014 March 21; 19(3): 3508-22.46Xie Y,Jiang ZH,Zhou H,Ma WZ,Wong YF,Liu ZQ,Liu L*. Thepharmacokinetic study of sinomenine, paeoniflorin and paeonol in ratsafter oral administration of a herbal product Qingfu Guanjiesu capsule byHPLC.Biomed Chromatogr.2014 Sep; 28(9):1294-302.45Wang JR,Yau LF,Zhang R,Xia Y,Ma J,Ho HM,Hu P,Hu M, Liu L*,.andJiang ZH*. Ginsenosides from notoginseng by artificial gastric juice canincrease cytotoxicity toward cancer cells. J Agric Food Chem.2014 Mar26;62(12):2558-73.44Parhira S, Yang ZF, Zhu, GY, Chen QL, Zhou BX, Wang YT, Liu L, Bai LP,Jiang ZH. In Vitro Anti-Influenza Virus Activities of a New Lignan Glycosidefrom the Latex of Calotropis gigantea. Plos One.2014 Aug 7;9(8):e104544.43Betty Y-K Law, W-K Chan, S-W Xu, J-R Wang, L-P Bai, L Liu* and K-WVincent Wong*. Natural small-molecule enhancers of autophagy induce autophagiccell death in apoptosis-defective cells. Scientific Reports 4,Published01 July2014 DOI:10.1038/srep0551042G-Y Zhu, G-Y Chen, L Liu, L-P Bai and Z-H Jiang. C17 Lactam-bearinglimonoids from the twigs and leaves of Amoora tsangii. J Nat Prod.2014;77(4):983-989.41S Parhira, G-Y Zhu, R-W Jiang, L Liu, L-P Bai and Z-H Jiang.2′-Epi-uscharin from the Latex of Calotropis gigantea with HIF-1 Inhibitory Activity. Scientific Report. 2014;4:4748.40J-R Wang, L-F Yau, R Zhang, Y Xia, J Ma, H-M Ho, P Hu, M Hu, M Liu* andZ-H Jiang*, Transformation of Ginsenosides from Notoginseng by artificialgastric juice can increase cytotoxicity towards cancer cells. J Agric FoodChem.2014;62(12):2558-2573.39G.-Y. Zhu, X.-J. Yao, L. Liu, L.-P. Bai, Z.-H. Jiang. Alistonitrine A, aCaged Monoterpene Indole Alkaloid from Alstonia scholaris. Organic Letters,2014, in press38Pei L,Shaozhen H,Gengting D,Tingbo C,Liang L,Hua Z.Effectivenessof Panax ginseng on Acute Myocardial Ischemia Reperfusion Injury WasAbolished by Flutamide via Endogenous Testosterone-Mediated Akt Pathway.Evid Based Complement Med.013;2013:817826.37Liang X,Wang JR,Wong KW,Hsiao WL,Zhou H,Jiang ZH,Kam KT, Liu*.Optimization of 2-dimensional gel electrophoresis for proteomic studiesof solid tumor tissue samples. Mol Med Rep.2014 Feb;9(2):626-32.36Wu AG,Wong VK,Xu SW,Chan WK,Ng CI,Liu L*,.and Law BY*,.Law BY.Onjisaponin B derived from Radix Polygalae enhances autophagy andaccelerates the degradation of mutant α-synuclein and huntingtin in PC-12 cells.In.J.Mol Sci.2013 Nov 15;14(11):22618-41.35Wu JL,Leung EL,Zhou H,Liu L*, and Li N. Metabolite analysis oftoosendanin by an ultra-high performance liquid chromatography-quadrupole-time of flight mass spectrometry technique. Molecules.2013 Sep30;18(10):12144-53.34 Vincent Kam Wai Wong, Molly Miao Zhang, Hua Zhou, Kelly Yin Ching Lam, Po Ling Chan,Carmen Ka Man Law, Patrick Ying Kit Yue, and Liang Liu*,. Saikosaponin-d enhances the anti-cancer potency of TNF-α via overcoming its undesirable response of activating NF-kappaB signallingin cancer cells. Evidence-Based Complementary and Alternative Medicine (eCAM).2013.2.33Wang,T.Y., Zhou,H., Leung,E., Wong,Y.F., Wu,P.K., Hsiao,W. , Liu, L.*The Predicted Proteomic Network Associated with the Anti-arthritic Action of QingfuGuanjieshu in Collagen II-induced Arthritis in Rats. Evidence-Based Complementary and Alternative Medicine.2013.32V-K-W Wong, T Li, B-Y-K Law, E-D-L Ma, N-C Yip, F Michelangeli, C-K-MLaw, M-M Zhang, K-Y-C Lam, P-L Chan and Liang Liu*. Saikosaponin-d, a novelSERCA inhibitor induces autophagic cell death in apoptosis-defective cells. CellDeath & Diseases.2013; (4):e720.31Vincent Kam Wai Wong, Molly Miao Zhang, Hua Zhou, Kelly Yin Ching Lam, PoLing Chan, Carmen Ka Man Law, Patrick Ying Kit Yue, and Liang Liu*.Saikosaponin-denhances the anti-cancer potency of TNF-α via overcoming itsundesirable response of activating NF-kappaB signalling in cancer cells.Evidence-Based Complementary and Alternative Medicine (eCAM). 2013 March13; Volume 2013. Article ID 74529530Wang, T .Y., Zhou, H., Leung, E., Wong, Y.F., Wu, P.K., Hsiao, W. , Liu, L.*.The predicted proteomic network associated with the anti-arthritic action ofQingfuGuanjieshu in collagen II-induced arthritis in rats. Evidence-Based Complementary and Alternative Medicine. 2013 May 28; Volume 2013, Article ID582493,29 Li, T., Yan, F.G., Wang ,R., Zhou H, Liu, L.*. Shikonin suppresses human TLymphocyte activation through inhibition of IKKb activity and JNKphosphorylation. Evidence-Based Complementary and Alternative Medicine. 2013May 17; Volume 2013, Article ID 37953628E-L-H Leung, Z-W Cao, Z-H Jiang, H Zhau and Liu, L.* . Network-based drugdiscovery by integrating systems biology and computational technologies.Briefings in Bioinformatics. 2012 Aug 9. [Epub ahead of print]27H-Y Zhang, J-R Wang, L-F Yau, H-M Ho, C-L Chan, P Hu, Liu, L.* and Z-HJiang. A cellular lipidomic study on the Aβ-induced neurotoxicity andneuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profilingand multivariate analysis. Mol Bio Syst.2012; 8(12):3208-3215.26 J-R Wang, H Zhou, X-Q Yi, Z-H Jiang and Liu, L.*. Total ginsenosides of radixginsend modulates tricarboxylic acid cycle protein expression to enhancecardiac energy metabolism in ischemic rat heart tissues. Molecules.2012;17(11):12746-12757.25R Ding, J-S Tang, H Gao, T Li, H Zhou, L Liuand X-S Yao. New methymycinderivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effectson human T cell proliferation mediated by PMA/ionomycin. Arch Pharm Res. 2012;35(9):1567-1572.24 X-Y Tian and Liu, L.*. Drug discovery enters a new era with multi-targetintervention strategy. Chin J Integr Med. 2012; 18(7),539-542.23Zhu, Lin; Lu, Jing-Guang; Li, Ting; Zhu, Guo-Yuan; Han, Quan-Bin; Hsiao,W.L.Wendy; Liu, Liang* and Jiang, Zhi-Hong* (2012). Immunosuppressive DecalinDerivatives from Red Yeast Rice. J. Nat. Prod. 75(4):567-571.22Fan,Y.F., Xie, Y., Liu, L., Ho, H.M., Wong, Y.F., Liu, Z.Q.*, Zhou, H.*Paeoniflorin reduced acute toxicity of aconitine in rats is associated with thepharmacokinetic alteration of aconitine. J Ethnopharmacol. 2012; 141(2): 701-708.21Liu, L.*, Leung, Elaine L.H. and Tian, X.Y. (2011). The clinical trial barriers.Nature 480(7378): S10020 Dong, H., Bai, L.P., Wong, V.K.W., Zhou, H., Wang, J.R.,Liu,Y., Jiang, Z.H.*,Liu, L.* (2011) Anti-cancer activity-structure relationship of ginsenosides andtheir derivatives in vitro. 2011 Dec 14; Molecules. 16(12):10619-3019Wong, Vincent K.W. & Liu, L* (2011) Integrin activation as an alternativetreatment approach for inflammatory diseases. Acta Pharmacologica Sinica (2011)32: 1309–1310.18Tang, L., Gong Y, Lu, C, Liu, L. & Liu, Z.Q. * (2011) Pharmacokinetics ofaconitine as the target marker of Fuzi (Aconitum carmichaeli) following singleand oral administrations of Fuzi extracts in rat by UPLC/MS/MS. Journal ofEthnolopharmarcology. 141(2):736-74117Hou, S.Z., Su, Z.R., Chen, S.X., Ye, M.R., Huang, S., Liu, L., Zhou, H.*, Lai,X.P.* (2011) Role of the interaction between puerarin and the erythrocytemembrane in puerarin-induced hemolysis. Chemico-Biological Interactions. 2011Jul 15;192(3):184-92.16Zhou, H.*, Hou, S. Z., Luo, P., Zeng, B., Wang, J.R., Wong, Y .F., Jiang, Z.H.,Liu, L.* (2011) Ginseng protects rodent hearts from acute myocardial ischemiareperfusion injury through GR/ER-activated RISK pathway in an endothelial NOS-dependent mechanism. Journal of Ethnolopharmarcology. 2011 May 17; 135(2):287-98.15 Luo, P.,Wong, Y.F., Ge, L., Zhang, Z.F., Liu, Y., Liu, L. & Zhou, H.* (2010)Anti-inflammatory and analgesic effect of plumbagin through inhibition ofnuclear factor-kappa B activation. Journal of Pharmacology and ExperimentalTherapeutics.Published online before print September 21, 2010, doi:10.1124/jpet.110.17085214 Hsiao, W. L. Wendy* & Liu, L. (2010) The role of traditional Chinese herbalmedicines in cancer therapy--from TCM theory to mechanistic insights. PlantaMedica. 76(11):1118-3113 Wong V.K., Cheung, S.S., Li, T., Jiang, Z.H., Wang, J.R., Dong, H., Yi, X.Q.,Zhou, H.* & Liu L.* (2010) Asian ginseng extract inhibits in vitro and in vivogrowth of mouse Lewis lung carcinoma cells via modulation of ERK-p53 and NF-kappaB signaling. Journal of Cellular Biochemistry. 111(4):899-91012 Yi, X.Q., Li, T., Wong, K.W.V., Yi, X.Q., Wong, Y.F., Zhou, H.* & Liu, L.*(2010) Total ginsenosides increase coronary perfusion flow in the isolated rathearts through activation of PI3K-eNOS signaling. Pytomedicine. 17(13):1006-1511 Huang, W. H., Yang, Z. J.*, Wu, H., Wong, Y. F., Zhao, Z. Z. & Liu, L. (2010)Development of liposomal salbutamol sulfate dry powder inhaler formation.Biological & Pharmaceutical Bulletin. 33(1):40-4610 Li, T., Wong, K.W.V., Yi, X.Q., Wong, Y.F., Zhou, H.* & Liu, L.* (2010) Matrineinduces T cell anergy in human Jurkat cells. Biological & PharmaceuticalBulletin. 33(1):40-469 Li, T., Wong, V. K., Yi, X. Q., Wong, Y. F., Zhou, H.* & Liu, L.* (2009)Pseudolaric acid B suppresses T lymphocyte activation through inhibition of NF-kappaB signaling pathway and p38 phosphorylation. Journal of CellularBiochemistry. 108(1):87-95.8 Wong, K.W.V, Zhou, H., Cheng, S.F.S, Li, T. & Liu, L.* (2009) Mechanistic studyof Saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.Journal of Cellular Biochemistry. 107(2):303-3157 Zhou, H., Wong, Y.F., Wang, J. & Liu, L.* (2008) Sinomenine Amelioratesarthritis via MMPs, TIMPs and cytokines in Rats. Biochemical and BiophysicalResearch Communications. 376(2):352-7.6 Xu, M. *, Chen, Q., Deng, B., Cai, X. & Liu, L. (2008) Sinomenine versus NSAIDsfor the symptomatic treatment of rheumatoid arthritis: a systematic review.Planta Medica. 74(12):1423-1429.5Wong, Y.F., Zhou, H., Wang, J.R., Xie, Y., Xu, H.X. & Liu, L.* (2008) Anti-Inflammatory and analgesic effects and molecular mechanisms of JCICM-6, a purified extract derived from an anti-arthritic Chinese herbal formula.Phytomedicine. 15(6-7):416-26.4 Wang, J.R., Zhou, H., Jiang, Z.H., & Liu, L.* (2008) Two new triterpene saponinsfrom the anti-inflammatory saponin fraction of Ilex pubescens root.Chemistry& Biodiversity. 5(7):1369-76.3 Xie, Y., Zhou, H., Wong, Y.F., Liu, Z.Q., Xu, H., Jiang, Z.H. & Liu, L.* (2008)An optimized high-performance liquid chromatography (HPLC) method forbenzoymesaconotine determination in the processed Radix Aconiti LateralisPreparata (Fuzi, aconite roots) and its products. Chinese Medicine. 3(1):6-10.2 Wang, J.R., Zhou, H., Jiang, Z.H., Wong, Y.F. & Liu, L.* (2008) In vivo anti-inflammatory and analgesic activities of a purified saponin fraction derivedfrom the root of Ilex pubescens. Biological & Pharmaceutical Bulletin.31(4):643-50.1 Xie, Y., Zhou, H., Wong, Y.F., Xu, H.X., Jiang, Z.H. & Liu, L.* (2008) Studyon the pharmacokinetics and metabolism of paeonol in rats treated with purepaeonol and an herbal preparation containing paeonol by using HPLC-DAD-MSmethod. Journal of Pharmaceutical and Biomedical Analysis. 46(4):748-56.近年出版的主要学术专著:6Chapter of “King of Herbs-Ginseng” in the book of the Way of Searching for Green Medicines”, edited by Peng Rong and Zhao Zhenzhong, publisged by China Medical Technology Press. Jan 20105Essentials of Chinese Medicine (Volume I, II, III), English Textbook of Chinese Medicine. One of the two Editors.Published by Springer,UK, 20094Safe and ReasonableApplicationof Chinese Herbal Medicine. Editor-in-Chief.Published by the Wan Li Press of Hong Kong, 20093International Standard of the Basic Terms of Traditional Medicine (English). Reviewerforthe proof reading, Published by the Western Pacific Regional Office of WHO, 20072Chinese Medicinal Therapy for 31 Common Metropolitan Illnesses. Editor-in-Chief. Press by the Wan Li Press of Hong Kong, 2007, Hong Kong1Research Methodology and Practices of Chinese Medicine. A textbookfor Taught Master of Chinese Medicine programme of the School of Chinese Medicine, Hong Kong Baptist University, Editor-in-Chief. Published by Hong Kong Baptist University Press, 2004, Hong Kong近年来的特邀学术会议报告:52Liang Liu,KW Vincent Wong, LH Elaine Leung. A new strategy for the studyof anti-cancer by Chinese herbal medicine ---Modulation on cancermetabolism. 19 July, 2014, Guangzhou, China51Liang Liu,Ting Li, WK Vincent Wong. Discovery of Cys-46, new drugbinding site for discovey of anti-arthritic therapeutics. Annual Meeting ofGuangdong Provincial Society of Chinese Medicine on Rhematism. 12 July,2014, Guangzhou, China50Liang Liu.Chinese medicine and cutting-age science and technology. FirstAnnualy Meeting of the Diagnosis Committee of Traditional Chinese Medicine,World Federation of Chinese Medicine Societies. 30 May, 2014, Changsha, China49Liang Liu.Anti-rheumatism by traditional Chinese medicine. Lecture Series byDistingulish Scholars. Hunan University of Traditional Chinese Medicine. 5December, 2013, Changsha, China48Liang Liu.Status and perspective of Chinese medicine development in MacauUniversity of Science and Technology. Organized by the State Key Laboratoryof Quality Research in Chinese Medicine.November 28-29, 2013, Macau,China47Liang Liu.Studies on the molecular targeting innovative drugs from Chineseherbal medicine. Forum on Translational Chinese Medicine. 19 Oct, 2013,Guangzhou, China46Lang Yi, Yan Dong, Hua Zhou, Jinfang Luo, Liang Liuand Peixun Wang.Mechanistic studies on the anti-inflammatory effect of sinomenine viacholigenic anti-inflammatory pathway. Seventh National Meeting on TCMImmunology. 9-10November, 2013, Nanchang, China45Hua Zhou, Yonghua Zhao and Liang Liu. Development of Chinese medicineeducation and research for 13 years. The Third International Congress on TCMEducation. 9-10 Nevember, 2013, Nanjing, China.44Liang Liu. R&D of the molecule-targeting innovative drugs from Chinesemedicinal herbs. Seventh National Meeting on TCM Immunology. 9-10November, 2013, Nanchang,China43Liang Liu.R&D of the inovative a ntiarthritic drugs from TCM. InternationalSumitForum on Innovative Drugs. 8-9 November,2013, Nanchang, China42Liu, L.Suppression of carcinoma growth and molecular targets of the ethanol extracts ofPanax ginseng. 2013 Annual Meeting of Pharmaceutical Sciences of Korea. , 1-4 July, 2013 , Seoul, Korea41Li,T., Wong,V.K.W., Jiang,Z.H., Zhou,H., Liu,L.Vincent. Discovery of a novel drug binding site on IKK-beta responsiblefor suppression of inflammation and arthritis. Summit on Quality Research and Innovative Drug Discovery, April 15-16, 2013, Macau40Liu, L.& Wong, Vincent. Studies on the anti-cancer effect and mechanism of Ginseng. Forum on Anti-cancer and Anti-aging. October 13, Taiwan39Liu, L & Richard Kam. Proteomic technology ---a powerful tool for identifying the network-based regulatory mechanisms of Chinese herbal medicine. International Forum on the Research of Network and Chinese Medicine.November 12-13, 2012, Adelaide, Australia38Liu, L.Li, T. & Wong, Vincent. A novel drug binding site on IKK-beta responsible for anti-inflammation and anti-arthritis. Conference on Natural Products Research of International Pharmacological Society.November 8, 2012, Macau37Liu, L.Li, T. &Wong, Vincent. Discovery of novel drug binding site Cys-46 on IKK-beta. International Conference on Natural Product Research. October 26-27, 2012, Shanghai, China36Liu, L.,Zhou, H. & Jiang Z.H. Screening innovative drugs from Medicinal herbs. 27thInternational Meeting on Natural Products. October, 6, 2012, Taiwan35Liu, L.Quality research on Chinese medicines and innovative drugs by using multi-cutting aged technologies. Forum on Chinese Medicine Research. September 14, Hong Kong34Liu, L.∗Li, Z.J., Leung, Elaine, Jiang, Z.H. & Zhou H. Urgent need of establishing international standards for globalization of traditional Chinese medicine. 11th Meeting of Consortium for Globalization of Chinese Medicine.August 24-26, 2013, Macau33Liu, L.(2012) Screening of the Component Compound-Compound Drugs from Chinese Herbal Medicine. The 323th Session of Xiang Shan Science Conference of China–Research and Development of the Component Chinese Drugs from Chinese Herbal Medicine.March 21-23, Beijing, China32Liu, L. & Elain Leung. (2012) Screening Strategy for Multi-target Innovative Drugs. Symposium on Chinese Medicines Quality and Innovative Drugs. Organized by the State Key Laboratory of Quality Research in Chinese Medicine (MUST). Feb 13-14, Macau, China31Liu, L.(2011) Progress for the establishment of State Key Laboratory of Quality Research in Chinese Medicine. Annual Meeting on Science and Technology Collaboration between the Mainland and Macau.Organized by the Committee of Science and Technology Collaboration between the Mainland and Macau. 12-13 September, Xian, China30Liu, L., Vincent Wong, Jiang Z.H. & Zhou, H. (2011) Studies of the ethanol extracts of ginseng and the derivatives of ginsenosides on anticancer. International Forum on the Development of Traditional Chinese Medicine-The 4th Session of the 13th Annual Meeting of China Association for Science and Technology.Organized by China Association for Science and Technology. 21-23 September, 2011, Tianjin, China29Liu, L.How Chinese medicine has been developing as a focus area of research in Macau University of Science and Technology. 10th Meeting of Consortium for Globalization of Chinese Medicine.26-28August,2011, Shanghai, China28Liu, L., Jiang, Z.H., Zhou, H. and Wong, J.W.Screening for innovative molecular targeting drugs from Chinese medicines through utilyzation of the cutting-age technologies in biology and analytical chemistry. Forum on Establishment of a Chinese Medicine Industry Park Through Partnership between Guangdong and Macau.Organized by Cross-Strait Scientific Collaboration Centre for Chinese Medicine. 14 December, 2010. Macau27Liu, L.The application potential of Chinese medicine research for treatment of cancer. Forum on Prevention and Treatment of CancersUsing Integrated Chinese and Western Medicine. Organized by Health Society of Hong Kong, 11 December, 2010,Hong Kong26Liu, L.& Tian, X. Y. Drug discovery enters a new era with multi-target intervention strategies. The ThirdInternational Conference andExposition on Modernization of Traditional Chinese Medicine. 24-26 November, 2010. Chengdu, China25Liu, L., Jiang, Z.H., Zhou, H. and Wong, J.W. R&D of the novel target-based drugs from Chinese medicines by utilyzation of high-tech biological and analytical chemical techlonogies. The First Summit on R&D of Southen Chinese Medicines.23 October, 2010. Guangzhou, China.24Liu, L.The anti-cancer effect and mechanism of the ethanol extracts of Asian ginseng. 7th World Congress of Chinese Medicine.1-3October,2010. Hague, The Netherlands23Liu, L.Potentials of Chinese medicine research on treatment of cancerous conditions. Forum on Chinese Medicine Research.Organized by Cross-Strait Scientific Collaboration Venter for Chinese Medicine. 26 September, Taiwan22Liu, L.Potentials of Chinese medicine research through utilization of proteomic technology. 6thForum of Chinese Scientists Association –Scientific Foundations on Traditional Medicine. 18-21 May, 2010, Fuzhou, China21Liu, L.Introduction of the educational system of Chinese medicine in Hong Kong. The1thInternational Congress and Forum of Asian Acupuncture.20-21 December, 2009, Taichung, Taiwan20Liu, L.A proposalfor the establishment of the Mainland and Hong Kong Closer Academic-research-and-development Partnership Arrangement (CAPA). Symposium on the Establishment of the Mainland and Hong Kong Closer Academic-research-and-development Partnership Arrangement (CAPA). 15 December, 2009. Hong Kong19Liu, L.Utilization of the omics technology in the field of Chinese medicine research. Summit on IntegrativeChinese and Western Medicine in China vs Launching Ceremony of the Collections of Publications on the Study of Professor Li En’s Thought.12-23 December, 2009. Beijing, China18Liu, L.and Vincent Wong. Studies of the anti-cancer effect and molecular mechanisms of the ethanol extractsof ginseng. 4thMeeting of Oncology in Guangdong, Hong Kong and Macau.5-6 December, 2009. Dongguan, China17Liu, L.Immunointervention and mechanism of natural compounds derived from medicinal plants. 40thAnnual Meeting of the Korean Society of Pharmacognosy. 2-4 December, 2009, Seoul, Korea16Liu, L.,Zhou,H., and Jiang,Z.H. Research and development of a novel botanical drug, GFGJS, for treatment of rheumatoid arthritis. International Conference on Traditional Medicine.9-11 November,2009. Guangzhou, China15Liu, L.and Zhou, H. Omics technology-A powerful tool for the study of Chinese medicine. The Fifth symposium on Chinese Medicine and Immunology.26-28October, 2009, Fuzhou, China14Liu, L.and Zhou,H. Rational assessment of pharmacological activities of chemicals from Chinese medicines and R&D of cocktail drug. 3rd Meeting of the International Conference of Modern Dosage Form and Technology ofChinese Medicines cum 2nd Meeting of Hospital Pharmacy of Chinese Medicines.12September,2009. Beijing, China13Liu, L.andZhou, H. Preliminary clinical trial of modified Qingfu Guanjieshu formula in treating rheumatoid arthritis. 8th Meeting of Consortium for Globalization of Chinese Medicine.26-28 August,2009. Nottingham, UK.12Liu, L.The educational system and quality accreditation of Chinese medicine in Hong Kong. 41th Annual Congress of the Japan Society of Medical Education.24-26 July. Osaka, Japan11Liu, L.Multi-target treatment for complicated diseases -Strategies for developing new therapeutics from TCM. Meeting on Academic Exchange between Hong Kong Scientists Association and Qinhua University.16 May, 2009,Beijing, China10Liu, L.The educational system of Chinese medicine in Hong Kong. The First Meeting of Global University Network in Traditional Medicine.6-8 May, 2009, Seoul, Korea9Liu, L.Developmen of Chinese medicine services and clinical research in Hong Kong. The First Meeting of Global University Network in Traditional Medicine. 6-8 May, 2009, Seoul, Korea8Liu, L.Chinese medicine treatment for rheumatoid arthritis. The World Conference on Chinese Medicine. 14 December, 2008, Hong Kong7Liu, L.& Zhou, H. The outcome-based teaching and learning method adopted in the reform of Chinese medicine undergraduate education. The First World Congress on Chinese Medicine Education. 5-6 November, 2008, Tianjin, China6Liu, L.Wong, K. W. Vincent, Zhou, H. & Li, T. What are the beneficial effects of ginseng for cancer patients? The 3th International Conference on Cancer Treatment by Traditional Medicine.1 November, 2008, Seoul, Korea5Wong, K.W., Zhou, H., Li, L. & Liu, L.Immunointervention of the smallmolecule derived from Chinese medicinal plants and potentials for treating autoimmune disorders –Saikosaponin-d. The 7thMeeting of the Consortium for Globalization of Chinese Medicine. 28-30 August, 2008, Taipei4Liu, L.,Zhou, H., Jiang, Z. H., Liu, Z.Q., Wang, J. R. & Yie, Y. Research and development of Chinese medicine by using omics technologies. The 323th Session of Xiang Shan Science Conference of China–Herbonomics Research .20-22 May, 2008,Beijing, China3Liu, L.,Jiang, Z.H., Zhou, H., Xie,Y. & Liu, ZQ. Research in Compound-compound Interactions would be promising for quality control of botanical products. 7thAnnual Oxford International Conference on the Science of Botanicals & American Society of Pharmacognosy 4thInterim Meeting. 12 –16April, 2008, Mississippi, USA.2Liu, L.and Zhou, H.Establishment of technical standards for the quality control of Chinese medicine by utilizing techniques and experts from Hong Kong, Macao, Taiwan and Mainland of China.Foundation Meeting of the Collaboration Center for Science and Technology in Chinese Medicine among Hong Kong, Macao, Taiwan and Mainland of China.23 February, 2008, Macau1Xu, M., Tian, X.Y., Chen, Q., Luk, L.F., Yu, S.F., Li, K.H. & Liu, L.Traditional herbal formulae in the treatment of rheumatoid arthritis: a quantitative analysis of clinical data. The 3rdInternational Functional Food Symposium.2008;6-7, Hong Kong.

推荐链接
down
wechat
bug